STOCK TITAN

Medtronic (NYSE: MDT) grants PSUs, RSUs and options to EVP Kiil

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medtronic plc EVP & President Cardiovascular Harry Skip Kiil received several equity awards. On August 3, 2026 he was granted 23,074 performance share units that may result in between 0 and 55,378 shares depending on three-year performance measured through April 27, 2029, 65,556 stock options with an $86.68 exercise price expiring in 2036, and 9,230 restricted stock units that vest fully on the third anniversary of grant.

On July 31, 2026, 3,074 ordinary shares were withheld at $85.39 per share to satisfy tax obligations upon the vesting of previously granted restricted stock units.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider KIIL HARRY SKIP
Role EVP & President Cardiovascular
Type Security Shares Price Value
Grant/Award Performance Share Units F4, F5, F6 23,074 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F7 65,556 $0.00 $0.00
Grant/Award Ordinary Shares F3 9,230 $0.00 $0.00
Tax Withholding Ordinary Shares F1, F2 3,074 $85.39 $262K
Holdings After Transaction: Performance Share Units — 23,074 shares (Direct); Stock Option (Right to Buy) — 65,556 shares (Direct); Ordinary Shares — 43,669 shares (Direct)
Footnotes (7)
  1. F1. Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
  2. F2. Includes 286 shares acquired through dividend reinvestment since the last report filed by the reporting person.
  3. F3. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
  4. F4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  5. F5. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
  6. F6. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 23,074 shares will be issued. If maximum performance metrics are achieved, 55,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  7. F7. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Performance share units granted 23,074 units Grant to EVP & President Cardiovascular on August 3, 2026 tied to Medtronic common stock
Maximum PSU payout shares 55,378 shares Shares issued if maximum performance metrics are achieved over a three-year performance period
Stock options granted 65,556 options Right to buy Medtronic ordinary shares granted on August 3, 2026
Option exercise price $86.68 per share Exercise price for 65,556 stock options expiring on August 3, 2036
Restricted stock units granted 9,230 units Restricted stock units vest 100% on the third anniversary of the grant date
Shares withheld for taxes 3,074 shares Ordinary shares withheld at $85.39 per share on July 31, 2026 to satisfy tax on RSU vesting
Tax withholding share price $85.39 per share Price per share for 3,074 ordinary shares withheld for tax obligations
Dividend reinvestment shares 286 shares Additional shares acquired through dividend reinvestment since the last report
Performance share units financial
"Each performance share unit represents a contingent right to receive one share"
Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.
restricted stock units financial
"Represents restricted stock units that vest 100% on the third anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend reinvestment financial
"Includes 286 shares acquired through dividend reinvestment since the last report"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
exercisable financial
"These options become exercisable at the rate of 25% of the shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity awards did Medtronic (MDT) EVP Harry Skip Kiil receive on August 3, 2026?

On August 3, 2026, Harry Skip Kiil received 23,074 performance share units, 65,556 stock options at $86.68 per share, and 9,230 restricted stock units. These awards provide future rights to Medtronic ordinary shares subject to vesting and performance conditions.

How can Harry Skip Kiil’s Medtronic (MDT) performance share units pay out?

The grant consists of 23,074 performance share units (PSUs), each tied to one Medtronic share. Over a three-year period, the payout ranges from 0 shares if minimum performance is not met to 55,378 shares if maximum performance metrics are achieved.

What are the terms of Harry Skip Kiil’s Medtronic (MDT) stock options?

Harry Skip Kiil was granted 65,556 stock options with an exercise price of $86.68 per share, expiring on August 3, 2036. These options become exercisable at 25% of the shares per year, starting on the first anniversary of the grant date.

When do Harry Skip Kiil’s 9,230 Medtronic (MDT) restricted stock units vest?

Harry Skip Kiil’s grant of 9,230 restricted stock units vests 100% on the third anniversary of the August 3, 2026 grant date. Once vested, each restricted stock unit represents one Medtronic ordinary share, assuming all vesting conditions are satisfied.

Why were 3,074 Medtronic (MDT) shares disposed of on July 31, 2026?

On July 31, 2026, 3,074 ordinary shares were disposed of at $85.39 per share to satisfy tax obligations. These shares were withheld in connection with the vesting of previously granted restricted stock units, rather than being sold as a discretionary transaction.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KIIL HARRY SKIP

(Last)(First)(Middle)
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MINNESOTA 55432

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & President Cardiovascular
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/31/2026F3,074(1)D$85.3934,439(2)D
Ordinary Shares08/03/2026A9,230(3)A$043,669D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Share Units(4)08/03/2026A23,074 (5) (5)Ordinary Shares23,074(6)$023,074D
Stock Option (Right to Buy)$86.6808/03/2026A65,556 (7)08/03/2036Ordinary Shares65,556$065,556D
Explanation of Responses:
1. Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
2. Includes 286 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
5. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
6. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 23,074 shares will be issued. If maximum performance metrics are achieved, 55,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
7. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)